Evidence of an interaction between TGF-β1 and the SDF-1/CXCR4/CXCR7 axis in human platelets

Dominik Rath1, Madhumita Chatterjee1, Annabell Holtkamp1

  • 1Department of Cardiology, University Hospital Tuebingen, Otfried-Mueller-Straße 10, Tuebingen, Germany.

Thrombosis Research
|June 18, 2016
PubMed

Insights

Platelets express TGF-β1 and SDF-1/CXCR4/CXCR7, which interact in coronary artery disease (CAD). SDF-1 stimulation increases TGF-β1 on platelets, suggesting a novel signaling pathway in CAD.

Area of Science:

  • Cardiovascular Biology
  • Platelet Signaling
  • Molecular Medicine

Background:

  • Transforming growth factor-beta 1 (TGF-β1), stromal cell-derived factor-1 (SDF-1), and its receptors CXCR4 and CXCR7 are present on human platelets.
  • Expression levels of these molecules are altered in symptomatic coronary artery disease (CAD) and influence patient outcomes.
  • The interplay between TGF-β1 and the SDF-1/CXCR4/CXCR7 axis in platelets, particularly in the context of CAD, remains poorly understood.

Purpose of the Study:

  • To investigate the potential crosstalk between TGF-β1 and the SDF-1/CXCR4/CXCR7 axis within human platelets.
  • To provide clinical and experimental evidence for interactions between these signaling molecules in the context of CAD.

Main Methods:

  • Analysis of platelet surface expression of TGF-β1, SDF-1, CXCR4, and CXCR7 in 284 CAD patients using flow cytometry.
  • In vitro stimulation assays using platelet-rich plasma treated with TGF-β1 or SDF-1, followed by flow cytometry analysis.
  • Multiple regression analyses to determine independent associations between TGF-β1 and SDF-1/CXCR4/CXCR7, considering clinical cofactors.

Main Results:

  • CXCR4 and CXCR7 expression significantly predicted TGF-β1 levels (p<0.001 for both).
  • SDF-1 stimulation led to a significant increase in platelet surface TGF-β1 expression (mean MFI 19.01 vs. 14.01, p<0.001).
  • Blocking CXCR4 or CXCR7 receptors with monoclonal antibodies significantly blunted the SDF-1-induced increase in TGF-β1 expression, while TGF-β1 stimulation did not affect SDF-1, CXCR4, or CXCR7 expression.

Conclusions:

  • This study presents the first clinical and experimental evidence of a cross-talk between TGF-β1 and the SDF-1/CXCR4/CXCR7 axis in human platelets.
  • This interaction does not appear to involve transcriptional modulation, differing from findings in other cellular systems.
Abstract

Related Concept Videos

TGF - &#946; Signaling Pathway01:16

TGF - β Signaling Pathway

The TGF-β signaling pathway regulates cell growth, differentiation, adhesion, motility, and development. TGF-β ligands that induce TGF-β signaling are synthesized in their latent form. Several proteases or cell surface receptors such as integrins act upon the latent form, releasing the active ligand. There are three types of mammalian TGF-βs: (TGF-β1, TGF-β2, and TGF-β3) that bind as homodimers or heterodimers to TGF-β receptors. The TGF-β receptors...
10.9K
Intracellular Signaling Affects Focal Adhesions01:17

Intracellular Signaling Affects Focal Adhesions

Integrins act both as extracellular input receivers and as intracellular processing activators. As their name suggests, integrins are entirely integrated into the membrane structure. Their hydrophobic membrane-spanning regions interact with the phospholipid bilayer's hydrophobic region. These membrane receptors provide extracellular attachment sites for effectors like hormones and growth factors. They activate intracellular response cascades when their effectors are bound and active.
Some...
3.8K
Formation of the Platelet Plug01:22

Formation of the Platelet Plug

The platelet phase, the second stage of hemostasis, commences around 15-20 seconds after an injury. It follows and overlaps with the vascular phase, during which blood vessels constrict to minimize blood loss.
As the injured blood vessel contracts, endothelial cells undergo contraction, revealing collagen fibers in the basement membrane and underlying connective tissue. Furthermore, the plasma membrane of endothelial cells becomes adhesive, preparing the site for platelet adhesion. Platelets...
10.5K
Structure and Function of Platelets01:18

Structure and Function of Platelets

The cell fragments known as platelets are disc-shaped, with an average diameter of about 3 μm and a thickness of roughly 1 μm. They play a crucial role in the body's vascular clotting system, which also involves plasma proteins, blood cells, and blood vessel tissues.
Platelets are continually replenished, circulating in the bloodstream for 9-12 days before being removed by phagocytes, primarily in the spleen. A microliter of circulating blood contains between 150,000 and 450,000...
4.5K
Regulation of Hematopoietic Stem Cells01:01

Regulation of Hematopoietic Stem Cells

All blood and immune cells are produced from the multipotent hematopoietic stem cells (HSCs) by the process of hematopoiesis. However, they all have a limited life span. In addition, many are depleted in immune surveillance or combatting an injury or infection. This makes blood one of the most regenerative tissues. Hematopoiesis helps replenish these blood and immune cells, restoring the body's normal functioning. However, overproduction of blood and immune cells can make them cancerous or...
4.3K
Regulation of Angiogenesis and Blood Supply01:24

Regulation of Angiogenesis and Blood Supply

Rapidly dividing tumors, embryos, and wounded tissues require more oxygen than usual, lowering the oxygen concentration in the blood. At low oxygen or hypoxic conditions, an oxygen-sensitive transcription factor called the hypoxia-inducible factor 1 or HIF1 is activated. HIF1 is a dimeric protein of alpha (ɑ) and beta (β) subunits.  Under optimal oxygen conditions, HIF1β is present in the nucleus while HIF1ɑ remains in the cytosol. HIF1ɑ is hydroxylated by prolyl...
3.9K